Corporate News 12-Mar-24
Suven Pharmaceuticals receives revision in credit ratings
Suven Pharmaceuticals announced that CRISIL has assigned the rating 'CRISIL A+/ Watch Positive (placed on rating watch with positive implications) / CRISIL A1+ (reaffirmed) for bank facilities of the company.
Previous News
Suven Pharma slips after Q3 PAT slides 56% YoY to Rs 47 cr
( Hot Pursuit - 06-Feb-24 12:07 )
Suven Pharmaceuticals consolidated net profit rises 10.29% in the March 2022 quarter
( Results - Announcements 09-May-22 14:13 )
Suven Pharma Hyderabad facilities clear USFDA inspection
( Hot Pursuit - 26-Feb-24 12:13 )
Suven Pharmaceuticals consolidated net profit rises 2.34% in the June 2022 quarter
( Results - Announcements 08-Aug-22 14:55 )
Suven Pharmaceuticals to convene AGM
( Corporate News - 10-May-22 15:08 )
Suven Pharmaceuticals to conduct board meeting
( Corporate News - 09-Aug-21 12:13 )
Suven Pharmaceuticals CFO resigns
( Corporate News - 22-Dec-23 19:50 )
CCI approves acquisition of 76.1% stake in Suven Pharma by Berhyanda
( Hot Pursuit - 21-Apr-23 12:03 )
Suven Pharma says Casper Pharma completes USFDA pre-approval inspection
( Hot Pursuit - 30-Jul-22 14:55 )
Suvan Pharmaceuticals to announce Quarterly Result
( Corporate News - 11-Aug-20 14:31 )
Board of Suvan Pharmaceuticals recommends special dividend
( Corporate News - 10-May-22 15:15 )
Other Stories
Gujarat Toolroom to conduct EGM
08-Jul-24 19:53
Macro Intl. to conduct AGM
08-Jul-24 19:52
Ecoboard Industries schedules AGM
08-Jul-24 19:52
Eraaya Lifespaces schedules EGM
08-Jul-24 19:52
Binny to convene EGM
08-Jul-24 19:52
ICRA upgrades long term rating on bank facilities of Keystone Realtors
08-Jul-24 19:17
Sadbhav Engineering schedules EGM
08-Jul-24 19:08
Board of Va Tech Wabag approves divestment of Wabag Romania
08-Jul-24 19:08
Global Capital Markets to announce Quarterly Result
08-Jul-24 19:07
Motherson Sumi Wiring India schedules board meeting
08-Jul-24 19:07
Back
Top